Real-world outcomes comparing the use of GLP-1 agonists in patients with multiple myeloma and comorbid obesity: A propensity score–matched analysis from a global federated health research network.
Arshi Syal(Thomas Jefferson University Hospital), Gàbor Varadi(Hadassah Academic College), Nitya Batra(Jacksonville College), Yajur Arya(Thomas Jefferson University Hospital), Angimar Uriepero Palma(Pennsylvania Hospital), Colton Jones(The University of Texas at San Antonio), Himil Mahadevia(Jacksonville College)
Cited by 1
Related Papers
Graft vs autoimmunity following allogeneic non-myeloablative blood stem cell transplantation in a patient with chronic myelogenous leukemia and severe systemic psoriasis and psoriatic polyarthritis
|Experimental Hematology|2000|111
Early Detection of Subclinical Visual Damage After Blast-Mediated TBI Enables Prevention of Chronic Visual Deficit by Treatment With P7C3-S243
|Investigative Ophthalmology & Visual Science|2014|91
Toxoplasmosis in organ transplant recipients: Evaluation, implication, and prevention
|Tropical parasitology|2016|80